2 results
Approved WMOCompleted
To compare the efficiency and safety of Continuous subcutaneous glucose monitoring compared to our standard care (bloodsamples obtained from an arterial or venous bloodsample and measured by the AccuChek.
Approved WMOCompleted
The aim of the study is to evaluate the efficacy of sensor augmented pump (SAP) therapy with MiniMed* 640G and SmartGuard* in preventing hypoglycemic events in comparison with continuous subcutaneous insulin infusion (CSII) therapy in type 1…